Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Maravai LifeSciences

4 Analysts Have This To Say About Maravai LifeSciences

Throughout the last three months, 4 analysts have evaluated Maravai LifeSciences (NASDAQ:MRVI), offering a diverse set of opinions from bullish to bearish.

This Pandemic Star Is Embroiled in CEO Drama

This Pandemic Star Is Embroiled in CEO Drama

Maravai LifeSciences had to undo a recent CEO change due to a lawsuit. Luckily, the drama should be resolved quickly.

Did Maravai LifeSciences Deserve to Sell Off on CEO Transition?

Did Maravai LifeSciences Deserve to Sell Off on CEO Transition?

The new CEO is a perfect fit for the company's growth plans. Sales will decline sharply anyway.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Stocks That Hit 52-Week Lows On Tuesday

On Tuesday, 44 companies hit new 52-week lows.

Benzinga's Top Ratings Upgrades, Downgrades For August 25, 2022

Maravai LifeSciences: Q4 Earnings Insights

Maravai LifeSciences (NASDAQ:MRVI) reported its Q4 earnings results on Wednesday, February 23, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

Organisations

B of A Securities

Danaher Corporation

Krystal Biotech

Dream Finders Homes

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Topics

inkl

Read news from The Economist, FT, and more,
with one subscription

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play